Levels of eight complement components and two control proteins, were determined on cord serum from normal full term neonates and serum from healthy infants aged 1 and 6 months. For all proteins, the levels were below the adult normal at birth and rose toward the adult range by age 6 months. In a second group of 271 patients, ages 1-36 months, serum Clq and properdin levels were measured. For both proteins, the mean values in early infancy were more than two SD below the adult range and did not reach the adult range until 18-21 months of age. The Clq concentration was more variable than that for any other component studied. In infants from 11 months-3 yr of age, Clq levels correlated with serum IgG levels, but properdin levels did not.
Speculation
Low serum complement levels in neonates may contribute to their increased susceptibility to infections. Correlations between synthetic rates of Clq and IgG is suggested as the mechanism responsible for the correlation in serum levels of these proteins after age 1 yr.
Complement is one of the humoral effectors necessary to integrate an immunologically competent organism (9, 16) . As a functional unit, it participates in antibody dependent and antibody independent immune reactions as a first line effector of the immune response. The study of clinical syndromes associated with genetic defects of individual complement components (1, 2) has helped to elucidate the variety of ways in which complement participates in immunologic defense mechanisms. Neonates and infants have been shown to have relative deficiencies of some of the components of the complement system (3, 5, 6, 11, 16, 17, 19) . In order to confirm the results showing low levels of serum complement in infancy and expand them to include a more complete evaluation of the complement profile, the serum levels of Clq, C2, C3, C4, C5, C6, factor B, properdin, C3b inactivator (C3bINA), and P l H were measured on neonates and on infants aged 1 and 6 months and compared to normal adult levels. In addition, the maturation of the complement pathway was examined by measuring serum Clq and properdin levels beginning at age 1 month and extending through age 35 months.
-~ecreased serum Clq levels found-in individuals with hypogammaglobulinemia of various etiologies (8, 12, 13) are thought by some to reflect either decreased synthesis (8, 11) and by others, increased catabolism (13) of this protein. The levels of Clq in infancy may, therefore, reflect both the maturation of the complement system and the serum IgG level. In order to help separate these influences. the correlations between serum IeG and Cla and. as a control, between IgG and properdin levels &re analyzed for infants between I and 35 months of age.
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MATERIALS AND METHODS
Serum was obtained prospectively with parental consent from cord blood of 10 normal full term neonates and from 20 normal infants. Ten of the infants were age 1 month, and 10, age 6 months. Specimens were also obtained from 50 normal adults. Complement components were measured on fresh serum or after storage at -70°C. Measurement of serum levels of Clq, C2, C3, C4, C5, C6, factor B, C3bINA, properdin, and PlH was by radial immunodiffusion using monospecific antisera made in this laboratory (7, 15, 20) .
In addition, the results of automated immune precipitation (AIP) analysis (4) of serum samples submitted to the laboratory of the Children's Hospital from March, 1975 through July, 1976 were reviewed. Serum from 27 1 patients whose ages ranged from I through 35 months in whom AIP analysis revealed normal levels for age of IgG, IgA, IgM, C3, C4, haptoglobin, and albumin were selected for analysis of Clq and properdin levels. The norms used for C3 and C4 levels were those established by the prospective study above. These serum specimens were stored at :2o0c until use. For purposes of data analysis, patients were grouped according to age; i.e., age I month = age 30-60 days.
RESULTS
COMPLEMENT PROFILES OBTAINED PROSPECTIVELY ON CORD SERUM AND ON THE SERUM OF INFANTS AGES I AND 6 MONTHS
As indicated in Table 1 , the complement components measured in cord serum had mean levels ranging from 49-76% of the adult means. By age 1 month, the levels of most components had risen somewhat, but a few remained the same. Only in the case of Clq was the mean level significantly lower than that in cord serum. C2, whose concentration was relatively highest in cord serum was the only component to reach normal adult levels by age one month. At 6 months of age, C2, C4, C5, C6, and factor B had mean concentrations not significantly different from the adult means, whereas the mean concentrations of the remaining complement components and control proteins, Clq, C3, properdin, C3bINA, and PlH, remained below those for adults. As indicated by the ranges of values, the complement levels from some individuals were within two SD of the adult means at all the ages studied.
RETROSPECTIVE ANALYSIS OF SERUM CLQ AND PROPERDIN LEVELS IN INFANCY
Clq levels in serum specimens submitted for AIP analysis from 271 infants aged 1-35 months are shown in Figure 1 . Serum properdin levels are shown in Figure 2 . The mean serum properdin levels at ages I and 6 months and the mean serum Clq level at 6 months in these infants are in good agreement with those found in infants at these ages in the prospective study. However, the mean Clq level at age 1 month was significantly greater in the 
' Abbreviations: H, hemolytic assay; R, radial immunodiffusion; E, electroimmunoassay; 1, levels reduced as compared to adult; f, levels increased as compared to adult; =, levels equal to that of adult.
Although the changes in mean Clq levels were not dissimilar to children aged 1-16 yr than in adults. The wide range was apparent those of other complement components studied, the concentration in the present data in both the retrospectively and prospectively of this component was much more variable than that in adults. obtained specimens. Thus, it is difficult to attribute it to acute Gewurz et al. (8) also reported a wider range of Clq values in phase reactions in patients in the retrospective study. Furthermore, the observations of Shutte el al. (18) indicate that, with surgical stress and inflammation, there is little change in the levels of either Clq or properdin.
In their study of Clq levels in individuals with decreased IgG synthesis, found a correlation coefficient (r = 0.395, P < 0.01) between serum IgG and Clq levels similar to that found in the 2-yr-old infants in the present study (r = 0.312, P < 0.05). In a later study, these same authors (13) found that, with low IgG levels, Clq was reduced because of increased catabolism rather than decreased synthesis, but they could not exclude the possibility that Clq synthesis was decreased in certain individuals with agarnrnaglobulinemia syndromes (8) . IgG levels in early infancy reflect both transplacentally acquired maternal IgG and IgG synthesized by the infant. If the serum Clq level in infancy is dependent upon the serum IgG level, then a correlation should exist between IgG and Clq levels throughout infancy. If, on the other hand, Clq and IgG synthesis are related, Clq levels would not correlate with IgG levels as long as significant amounts of maternal IgG circulate. The results of the authors show that Clq levels correlate least well with IgG levels in early infancy, when the contribution of maternal IgG to the total IgG is greatest. In infants over 10 months of age, with minimal amounts of maternal IgG, correlation coefficients between IgG and Clq were significant. The data for early infancy suggest that the serum level of IgG is not a determinant of the Clq level. The improvement in correlation as maternal IgG leaves the circulation suggests that the rate of synthesis of IgG is a strong influence on the Clq level.
